Showing results (191-200 of 336) with videos related to

Sort By:
Pageof 34
Oncogene|April 6, 2004
Gene expression-based, individualized outcome prediction for surgically treated lung cancer patientsShuta Tomida, Katsumi Koshikawa, Yasushi Yatabe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 8, 2018
EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to DacomitinibYoshihisa Kobayashi, Toshio Fujino, Masaya Nishino, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2018
Innate Genetic Evolution of Lung Cancers and Spatial Heterogeneity: Analysis of Treatment-Naïve LesionsKenichi Suda, Jihye Kim, Isao Murakami, et al.
Translational Lung Cancer Research|September 29, 2021
Activity and mechanism of acquired resistance to tarloxotinib in <i>HER2</i> mutant lung cancer: an <i>in vitro</i> studyTakamasa Koga, Kenichi Suda, Masaya Nishino, et al.
Aging and Disease|December 20, 2012
Genetic and Prognostic Differences of Non-small Cell Lung Cancer between Elderly Patients and Younger CounterpartsKenichi Suda, Kenji Tomizawa, Hiroshi Mizuuchi, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 13, 2013
Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201Hisao Asamura, Tomoyuki Hishida, Kenji Suzuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 25, 2018
[A Case of Resected Superior Sulcus Tumor with Pathological Complete Response after Trimodality Therapy]Masaya Nishino, Kenji Tomizawa, Syuta Ohara, et al.
International Journal of Cancer|April 20, 2004
Interferon-gamma differentially regulates susceptibility of lung cancer cells to telomerase-specific cytotoxic T lymphocytesKouhei Tajima, Yoshinori Ito, Ayako Demachi, et al.
Cancer Research|June 3, 2004
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survivalJunichi Takamizawa, Hiroyuki Konishi, Kiyoshi Yanagisawa, et al.
Lung Cancer (Amsterdam, Netherlands)|November 6, 2021
In vitro validation study of HER2 and HER4 mutations identified in an ad hoc secondary analysis of the LUX-Lung 8 randomized clinical trialAkira Hamada, Kenichi Suda, Takamasa Koga, et al.
Pageof 34